Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2007 3
2008 2
2009 1
2010 2
2011 2
2012 1
2013 2
2014 3
2019 1
2020 4
2021 4
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
AAV-mediated gene transfer for retinal diseases.
Allocca M, Tessitore A, Cotugno G, Auricchio A. Allocca M, et al. Among authors: cotugno g. Expert Opin Biol Ther. 2006 Dec;6(12):1279-94. doi: 10.1517/14712598.6.12.1279. Expert Opin Biol Ther. 2006. PMID: 17223737 Review.
Ocular gene therapy: current progress and future prospects.
Colella P, Cotugno G, Auricchio A. Colella P, et al. Among authors: cotugno g. Trends Mol Med. 2009 Jan;15(1):23-31. doi: 10.1016/j.molmed.2008.11.003. Epub 2008 Dec 25. Trends Mol Med. 2009. PMID: 19097940 Review.
Tumor Burden Dictates the Neoantigen Features Required to Generate an Effective Cancer Vaccine.
Garzia I, Nocchi L, Avalle L, Troise F, Leoni G, Seclì L, Antonucci L, Cotugno G, Allocca S, Romano G, Conti L, Caiazza C, Mallardo M, Poli V, Scarselli E, D'Alise AM. Garzia I, et al. Among authors: cotugno g. Cancer Immunol Res. 2024 Apr 2;12(4):440-452. doi: 10.1158/2326-6066.CIR-23-0609. Cancer Immunol Res. 2024. PMID: 38331413 Free PMC article.
Vector Aided Microenvironment programming (VAMP): reprogramming the TME with MVA virus expressing IL-12 for effective antitumor activity.
Seclì L, Infante L, Nocchi L, De Lucia M, Cotugno G, Leoni G, Micarelli E, Garzia I, Avalle L, Sdruscia G, Troise F, Allocca S, Romano G, Scarselli E, D'Alise AM. Seclì L, et al. Among authors: cotugno g. J Immunother Cancer. 2023 Apr;11(4):e006718. doi: 10.1136/jitc-2023-006718. J Immunother Cancer. 2023. PMID: 37117006 Free PMC article.
Phase I trial of viral vector based personalized vaccination elicits robust neoantigen specific antitumor T cell responses.
D'Alise AM, Leoni G, Cotugno G, Siani L, Vitale R, Ruzza V, Garzia I, Antonucci L, Micarelli E, Venafra V, Gogov S, Capone A, Runswick S, Martin-Liberal J, Calvo E, Moreno V, Symeonides SN, Scarselli E, Bechter O. D'Alise AM, et al. Among authors: cotugno g. Clin Cancer Res. 2024 Mar 20. doi: 10.1158/1078-0432.CCR-23-3940. Online ahead of print. Clin Cancer Res. 2024. PMID: 38506710
A chemical switch for controlling viral infectivity.
Hörner M, Kaufmann B, Cotugno G, Wiedtke E, Büning H, Grimm D, Weber W. Hörner M, et al. Among authors: cotugno g. Chem Commun (Camb). 2014 Sep 14;50(71):10319-22. doi: 10.1039/c4cc03292f. Chem Commun (Camb). 2014. PMID: 25058661
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' Prediction.
Leoni G, D'Alise AM, Tucci FG, Micarelli E, Garzia I, De Lucia M, Langone F, Nocchi L, Cotugno G, Bartolomeo R, Romano G, Allocca S, Troise F, Nicosia A, Lahm A, Scarselli E. Leoni G, et al. Among authors: cotugno g. Vaccines (Basel). 2021 Aug 9;9(8):880. doi: 10.3390/vaccines9080880. Vaccines (Basel). 2021. PMID: 34452005 Free PMC article.
33 results